Seniors in Metro Vancouver Invited to Participate in a Clinical Trial Assessing a New Immunomodulator Designed to Restore Immune Function in the Elderly
June 07, 2024 20:18 ET
|
Qu Biologics, Inc.
Vancouver, BC, June 07, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a Burnaby-based clinical-stage biotechnology company, is pleased to announce that the RESILIENCE Study, a clinical trial...
EnGeneIC and Singapore Institute of Advanced Medicine Holdings Forge Strategic Partnership to Revolutionise Cancer Treatment in Asia
June 06, 2024 21:13 ET
|
EnGeneIC
SYDNEY, Australia, June 06, 2024 (GLOBE NEWSWIRE) -- EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has...
Rapport Therapeutics Announces Pricing of Initial Public Offering
June 06, 2024 18:54 ET
|
Rapport Therapeutics, Inc.
BOSTON and SAN DIEGO, June 06, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational...
Pixalate Releases April 2024 Website MFA Risk Index for Open Programmatic Sellers (SSPs): Google AdExchange, Magnite Have Highest MFA Risk in April 2024
June 06, 2024 10:03 ET
|
Pixalate Inc.
LONDON, June 06, 2024 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released the April 2024 Web MFA Risk Analysis:...
BioNTX Announces 10th Annual iC³® Life Science & Healthcare Innovation Summit
June 06, 2024 10:00 ET
|
Bio North Texas
BioNTX, the leading biotechnology trade organization in North Texas, is thrilled to announce the 10th Annual iC³® Life Science Summit.
Qu Biologics and Foundation Medicine Collaborate to Impact the Care of Patients with Late-Stage Colorectal Cancer
June 06, 2024 08:00 ET
|
Qu Biologics, Inc.
BURNABY, British Columbia, June 06, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of...
Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress
June 06, 2024 08:00 ET
|
Madrigal Pharmaceuticals, Inc.
Late-breaking AI-based analysis of MAESTRO-NASH biopsy data demonstrates Rezdiffra improved key fibrotic features that are predictive of progression to decompensated cirrhosisNoninvasive test data...
Pixalate Releases Global Q1 2024 Made For Advertising (MFA) Websites Ad Spend Report: 10% of Global Open Programmatic Ad Spend Went to Likely MFA Sites in March 2024, 12% in North America, Followed by EMEA (8%), LATAM (8%), and APAC (6%)
June 05, 2024 14:17 ET
|
Pixalate Inc.
LONDON, June 05, 2024 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released the Q1 2024 Made For Advertising (MFA)...
AMEC Announces New Chair
June 05, 2024 10:34 ET
|
The International Association For The Measurement And Evaluation Of Communication (AMEC)
AMEC, the world’s largest media intelligence and insights professional body announced Raina Lazarova, Co-Founder of Ruepoint as new Chair
New Findings Revealed on Kyolic Aged Garlic Extract Research at 7th Annual International Garlic Symposium
June 05, 2024 10:00 ET
|
Wakunaga of America
MUNICH, June 05, 2024 (GLOBE NEWSWIRE) -- The latest research on Wakunaga of America’s Aged Garlic Extract (AGE) was presented at the 7th International Garlic Symposium: Frontiers of Garlic Research...